Verrica Pharmaceuticals Inc (VRCA)

May 12, 2025

Earnings To Watch: Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2025 Result - GuruFocus

May 12, 2025

May 11, 2025

Verrica Pharmaceuticals to Host Q1 2025 Earnings Call and Corporate Update - MSN

May 11, 2025

May 11, 2025

Verrica Pharmaceuticals (VRCA) Expected to Announce Earnings on Tuesday - Defense World

May 11, 2025

May 11, 2025

Head-To-Head Comparison: KalVista Pharmaceuticals (NASDAQ:KALV) and Verrica Pharmaceuticals (NASDAQ:VRCA) - Defense World

May 11, 2025

May 07, 2025

Verrica Pharmaceuticals at The Citizens JMP Life Sciences Conference: Strategic Developments in Dermatology - Investing.com Canada

May 07, 2025

May 07, 2025

Verrica Pharmaceuticals to Report First Quarter 2025 - GlobeNewswire

May 07, 2025

May 07, 2025

Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025 - The Manila Times

May 07, 2025

May 07, 2025

Renaissance Technologies LLC Grows Position in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) - Defense World

May 07, 2025

May 07, 2025

Verrica Pharmaceuticals CEO to Present at Citizens Life Sciences Conference - MSN

May 07, 2025

May 06, 2025

Invesco Ltd. Makes New $32,000 Investment in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) - Defense World

May 06, 2025

May 03, 2025

Geode Capital Management LLC Purchases 21,789 Shares of Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) - Defense World

May 03, 2025

Apr 30, 2025

Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York - GlobeNewswire

Apr 30, 2025

Apr 30, 2025

Exclusive: Verrica Pharmaceuticals CEO Takes Center Stage at Major Life Sciences Conference in NYC - Stock Titan

Apr 30, 2025

Apr 27, 2025

Verrica Pharmaceuticals to Present at Needham Healthcare Conference - MSN

Apr 27, 2025

Apr 18, 2025

GLP-1 Receptor Agonist Market Is Booming Worldwide 2025-2032: Verrica Pharmaceuticals, AbbVie Inc. - newstrail.com

Apr 18, 2025

Apr 13, 2025

Verrica Pharmaceuticals Appoints Dr. Noah Rosenberg as Chief Medical Officer - MSN

Apr 13, 2025

Apr 13, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Earns "Neutral" Rating from HC Wainwright - MarketBeat

Apr 13, 2025

Apr 11, 2025

New Drug Application Submitted in Japan for Verrica Pharmaceuticals’ TO-208 - MSN

Apr 11, 2025

Apr 11, 2025

Needham & Company LLC Reiterates “Hold” Rating for Verrica Pharmaceuticals (NASDAQ:VRCA) - Defense World

Apr 11, 2025

Apr 11, 2025

HC Wainwright Analysts Decrease Earnings Estimates for VRCA - Defense World

Apr 11, 2025

Apr 10, 2025

What is HC Wainwright’s Forecast for VRCA FY2028 Earnings? - Defense World

Apr 10, 2025

Apr 09, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Receives “Neutral” Rating from HC Wainwright - Defense World

Apr 09, 2025

Apr 09, 2025

Verrica Pharmaceuticals Reports Strong First-Quarter Growth for YCANTH - MSN

Apr 09, 2025

Apr 09, 2025

H.C. Wainwright maintains Neutral on Verrica stock after Q1 update By Investing.com - Investing.com Canada

Apr 09, 2025

Apr 08, 2025

Verrica Pharmaceuticals at Needham Conference: Strategic Restructuring and Growth By Investing.com - Investing.com Canada

Apr 08, 2025

Apr 08, 2025

Hold Rating on Verrica Pharmaceuticals Amid Liquidity Concerns and Uncertain Financial Strategy - TipRanks

Apr 08, 2025

Apr 07, 2025

In face of U.S. stock market selloff, shares of West Chester firm are on the rise - The Business Journals

Apr 07, 2025

Apr 07, 2025

Verrica Pharmaceuticals Reports Strong Demand-Led Growth In Ycanth® In Q1 2025 - marketscreener.com

Apr 07, 2025

Apr 07, 2025

Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025 - The Manila Times

Apr 07, 2025

Apr 07, 2025

Verrica Pharmaceuticals Reports Strong Demand-Led Growth in - GlobeNewswire

Apr 07, 2025

Apr 07, 2025

Record-Breaking Quarter: YCANTH Crosses 10K Units Milestone with 17% Growth - Stock Titan

Apr 07, 2025

Apr 05, 2025

Verrica Pharmaceuticals Adds Dr. Gavin Corcoran to Board of Directors - MSN

Apr 05, 2025

Apr 04, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Apr 04, 2025

Apr 03, 2025

Here's Why Verrica Pharmaceuticals (VRCA) Is a Great 'Buy the Bottom' Stock Now - MSN

Apr 03, 2025

Apr 03, 2025

Verrica Pharmaceuticals appoints new board member By Investing.com - Investing.com India

Apr 03, 2025

Apr 03, 2025

Verrica Pharmaceuticals appoints new board member - Investing.com Australia

Apr 03, 2025

Apr 02, 2025

Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors - GlobeNewswire

Apr 02, 2025

Apr 02, 2025

Palvella Therapeutics Announces Late-Breaking Presentation at Global Pediatric Dermatology Congress - MyChesCo

Apr 02, 2025

Apr 02, 2025

Verrica Pharmaceuticals expands board with new director By Investing.com - Investing.com Canada

Apr 02, 2025

Apr 02, 2025

Verrica Pharmaceuticals Appoints Dr. Corcoran as Director - TipRanks

Apr 02, 2025

Apr 02, 2025

Verrica Pharmaceuticals expands board with new director - Investing.com

Apr 02, 2025

Apr 02, 2025

Strategic Move: Verrica Adds Formation Bio CDO to Board Amid YCANTH Success - Stock Titan

Apr 02, 2025

Apr 02, 2025

Palvella Therapeutics Reports 2024 Financial Results and Advances Rare Disease Pipeline - MyChesCo

Apr 02, 2025